Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Share-based Compensation (2016 - 2025)

InspireMD (NSPR) has 16 years of Share-based Compensation data on record, last reported at $3.5 million in Q3 2025.

  • For Q3 2025, Share-based Compensation rose 45.07% year-over-year to $3.5 million; the TTM value through Sep 2025 reached $11.8 million, up 25.3%, while the annual FY2024 figure was $10.1 million, 125.79% up from the prior year.
  • Share-based Compensation reached $3.5 million in Q3 2025 per NSPR's latest filing, up from $3.2 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $3.5 million in Q3 2025 and bottomed at $289000.0 in Q1 2023.
  • Average Share-based Compensation over 5 years is $1.5 million, with a median of $930000.0 recorded in 2023.
  • Peak YoY movement for Share-based Compensation: tumbled 55.74% in 2023, then skyrocketed 805.88% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $566000.0 in 2021, then tumbled by 34.98% to $368000.0 in 2022, then skyrocketed by 348.1% to $1.6 million in 2023, then skyrocketed by 42.27% to $2.3 million in 2024, then surged by 51.07% to $3.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $3.5 million in Q3 2025, $3.2 million in Q2 2025, and $2.7 million in Q1 2025.